Use these structured checklists in clinic to identify and close adherence gaps.
Risk factors for nonadherence
Older child/adolescent age; longer treatment duration [7], [1]
Minority status, lower SES, caregiver stress/health behaviors [8], [1]
Negative treatment beliefs, side-effect concerns, stigma/embarrassment [3], [9]
Complex regimens, multiple devices, poor health literacy [10], [4]
Limited school support or fragmented home–school communication [10], [9]
Efficient adherence detection
Objective data: pharmacy refill, dose counters, electronic monitors when available [6]
Inhaler–spacer technique observation with checklist; re-demonstrate until correct [6]
Brief beliefs screen: necessity vs concerns; ask about side effects and routines [3]
Cross-check prescriber fidelity: correct dose/device, refills supplied, written plan given [6]
Use caregiver ‘admitted nonadherence’ questions—predictive of morbidity [2]
Core interventions that work
Simplify to once-daily ICS or single maintenance-and-reliever therapy where age/guidelines allow; minimize device types [4], [5]
Motivational interviewing to resolve ambivalence; align with family goals [3], [9]
Structured education with teach-back and written action plan; school coordination [10], [4]
Reminder systems: phone alarms, apps, smart inhalers; involve caregivers for refills [6]
Regular technique ‘booster’ sessions; spacer use in younger children [4], [6]
When to consider advanced therapies
After confirming poor control despite verified adherence/technique over time [4], [5]
Phenotype-driven add-ons and biologics for severe, uncontrolled disease [5]
Multidisciplinary review: allergy testing, environmental control, comorbidity management [4], [5]
Monitoring outcomes and safety
Track ACT/C-ACT scores, SABA canister counts, ED/OC visits, oral steroid bursts [4]
Growth monitoring with long-term ICS; discuss expected small effects and risk–benefit [4]
Document adherence metrics (frequency, technique, fidelity) at each visit [6]